Cellebrite DI Ltd. logo CLBT - Cellebrite DI Ltd.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $19.75 DETAILS
HIGH: $23.00
LOW: $15.00
MEDIAN: $20.50
CONSENSUS: $19.75
UPSIDE: 34.90%
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue
Revenue 475.7 401.2 325.1 270.7 246.2 194.9 171.9
Cost of Revenue 75.2 62.6 53.2 50.7 42.6 37.9 35.8
Gross Profit 400.5 338.6 271.9 219.9 203.7 157.0 136.0
Operating Expenses
R&D Expenses 113.9 98.4 84.4 80.6 65.5 54.4 46.6
SG&A Expenses 220.1 183.3 154.3 138.2 124.3 91.2 90.2
Other Expenses 0 0 0 0 0 2.3 0.8
Operating Expenses 334.0 281.7 238.6 218.9 189.9 147.8 137.6
Operating Income
Operating Income 66.5 56.9 33.2 1.0 13.8 9.2 (1.5)
Interest Expense 0 349.8 0 0.1 0.2 1.4 0.4
Interest Income 24.2 18.2 8.9 2.0 0.8 2.8 3.5
Profitability
EBITDA 103.1 (265.3) (65.4) 130.1 89.5 17.3 5.6
EBIT 91.2 (276.0) (75.4) 120.9 82.5 11.4 1.5
Income Before Tax 90.7 (276.0) (75.6) 120.8 82.3 11.4 1.4
Income Tax Expense 12.4 7.0 5.5 (0.0) 10.9 5.6 3.3
Net Income 78.3 (283.0) (81.1) 120.8 71.4 5.8 (1.9)
Per Share Data
EPS (Basic) 0.32 -1.35 -0.43 0.64 0.50 -0.05 -0.05
EPS (Diluted) 0.31 -1.35 -0.43 0.59 0.44 -0.05 -0.05
Shares Outstanding 252.7 209.5 190.2 182.7 144.0 187.2 187.2
Metric 2025 2024 2023 2022 2021 2020 2019
Current Assets
Cash & Cash Equivalents 124.5 191.7 189.5 87.6 146.0 128.7 76.5
Short-Term Investments 312.6 255.6 113.4 96.0 35.6 108.9 123.7
Net Receivables 105.0 82.4 77.3 78.8 67.5 66.3 44.2
Inventory 7.6 8.9 9.9 10.2 6.5 4.8 4.0
Other Current Assets 6.6 18.2 23.1 14.8 7.9 11.2 8.9
Total Current Assets 575.9 567.6 422.1 295.9 273.2 324.3 261.9
Non-Current Assets
Property, Plant & Equipment 38.5 27.6 30.2 32.9 16.8 16.1 14.8
Goodwill 119.6 28.7 26.8 26.8 26.8 9.5 0
Intangible Assets 81.5 11.3 10.6 11.3 11.2 6.6 0
Long-Term Investments 98.0 36.6 28.9 22.1 0 0 0
Other Non-Current Assets 14.6 7.7 12.9 1.7 2.0 0.6 0.4
Total Non-Current Assets 363.0 123.0 123.9 107.4 66.6 40.1 18.4
Total Assets 938.9 690.6 532.9 403.3 339.8 364.4 280.2
Current Liabilities
Account Payables 16.8 11.1 8.3 4.6 9.5 4.7 5.4
Short-Term Debt 0 0 0 0 0 0 0
Deferred Revenue 278.2 217.6 196.6 153.3 123.7 106.1 69.8
Other Current Liabilities 0 0 9.0 0 0 0 0
Total Current Liabilities 369.7 295.5 253.8 207.8 186.6 159.4 99.2
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0
Other Non-Current Liabilities 16.7 7.0 188.6 69.1 190.1 107.8 103.3
Total Non-Current Liabilities 84.9 59.0 244.8 121.7 226.6 141.2 122.3
Total Liabilities 454.5 354.5 498.7 329.4 413.1 300.6 221.4
Stockholders' Equity
Common Stock 0 0 0 0 0 0 0
Retained Earnings (86.5) (164.9) 118.1 199.2 78.4 28.3 32.6
Accumulated Other Comprehensive Income 2.2 2.1 1.1 0.3 1.4 1.3 0.8
Total Stockholders' Equity 484.3 336.0 34.2 73.9 (73.3) 63.8 58.8
Total Liabilities & Equity 938.9 690.6 532.9 403.3 339.8 364.4 280.2
Debt Metrics
Total Debt 22.7 11.0 14.1 15.4 0 0 0
Net Debt (101.8) (180.7) (175.4) (72.3) (146.0) (128.7) (76.5)
Metric 2025 2024 2023 2022 2021 2020 2019
Operating Activities
Net Income 78.3 (283.0) (81.1) 120.8 71.4 5.8 (1.9)
Depreciation & Amortization 11.9 10.6 10.0 9.2 7.0 5.9 4.1
Stock-Based Compensation 0 30.6 19.0 13.7 6.5 7.3 12.8
Change in Working Capital 42.0 42.0 38.5 (2.8) 20.7 49.7 2.7
Other Non-Cash Items 36.7 336.0 110.5 (117.9) (67.9) 0.7 0.1
Operating Cash Flow 169.0 132.2 102.1 20.6 36.1 66.5 16.1
Investing Activities
Capital Expenditure (13.2) (10.6) (7.9) (9.1) (8.1) (6.2) (6.2)
Acquisitions (147.5) (2.7) 0 0 (20) (15.0) 0
Purchases of Investments (321.2) (334.8) (144.3) (165.4) (21) (138.5) 0
Sales/Maturities of Investments 212.8 198.7 129.7 83.2 94.3 153.3 0
Other Investing Activities 0.9 (2.0) (2.7) (2.2) (3) 0 (40.5)
Investing Cash Flow (268.2) (149.5) (22.5) (91.2) 45.2 (6.4) (46.7)
Financing Activities
Net Debt Issuance 4.6 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 (0.1) (0.8)
Dividends Paid 0 0 0 0 (100) (10) (25)
Other Financing Activities 0 20.7 21.8 14.0 31.6 1.5 0.1
Financing Cash Flow 29.6 20.7 21.8 14.0 (68.4) (8.6) 75.5
Cash Position
Net Change in Cash (67.2) 2.1 101.9 (58.3) 12.1 52.2 44.9
Cash at Beginning 191.7 189.5 87.6 146.0 133.8 81.7 36.8
Cash at End 124.5 191.7 189.5 87.6 146.0 133.8 81.7
Free Cash Flow 155.7 121.6 94.1 11.5 27.9 60.3 9.9
Key Metrics 2025 2024 2023 2022 2021 2020 2019
Income Statement
Revenue 475.7 401.2 325.1 270.7 246.2 194.9 171.9
Gross Profit 400.5 338.6 271.9 219.9 203.7 157.0 136.0
Operating Income 66.5 56.9 33.2 1.0 13.8 9.2 (1.5)
Net Income 78.3 (283.0) (81.1) 120.8 71.4 5.8 (1.9)
EPS (Diluted) 0.31 -1.35 -0.43 0.59 0.44 -0.05 -0.05
Balance Sheet
Cash & Equivalents 124.5 191.7 189.5 87.6 146.0 128.7 76.5
Total Assets 938.9 690.6 532.9 403.3 339.8 364.4 280.2
Total Debt 22.7 11.0 14.1 15.4 0 0 0
Stockholders' Equity 484.3 336.0 34.2 73.9 (73.3) 63.8 58.8
Cash Flow
Operating Cash Flow 169.0 132.2 102.1 20.6 36.1 66.5 16.1
Capital Expenditure (13.2) (10.6) (7.9) (9.1) (8.1) (6.2) (6.2)
Free Cash Flow 155.7 121.6 94.1 11.5 27.9 60.3 9.9